Logo for Karyopharm Main Menu Corporate Governance > Committee Composition Committee Composition Karyopharm Therapeutics has the committees listed below in place. The grid below provides an overview of the individuals that make up each committee. To learn more about a particular committee or an individual member click the titles below. Audit Committee Commercialization and Portfolio Committee Compensation Committee Nominating, Governance and Compliance Committee Garen Bohlin Mikael Dolsten, MD, PhD Barry E. Greene Mansoor Raza Mirza, MD Christy Oliger Deepa R. Pakianathan, PhD Chen Schor Chair Member © Karyopharm, 2020. All Rights Reserved. Terms of Use Privacy Policy Site Map

Logo for Karyopharm Main Menu Analyst Coverage Below is a list of individual analysts that we are aware of that currently follow Karyopharm Therapeutics. Please note, that any opinions, estimates or forecasts regarding performance made by these analysts do not represent Karyopharm Therapeutics or its management team. Karyopharm Therapeutics is under no obligation to update this list, thus it may not be complete or up to date. Firm Analyst Baird Colleen Kusy Barclays Peter Lawson Canaccord Arlinda Lee H.C. Wainwright & Co. Ed White Jefferies, LLC Maury Raycroft JP Morgan Eric Joseph SVB Leerink Jonathan Chang Morgan Stanley Michael Ulz RBC Capital Markets Brian Abrahams Wedbush David Nierengarten © Karyopharm, 2020. All Rights Reserved. Terms of Use Privacy Policy Site Map

Logo for Karyopharm Main Menu Stock Information > Historical Stock Price Historical Stock Price Select the date below to view the historical closing price for that particular day. The closing price is not indicative of future price performance. Historical Stock Prices are provided for informational purposes only and are not intended for trading purposes. NASDAQKPTI Select A Date Month Year Su Mo Tu We Th Fr Sa 25 26 27 28 29 30 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 1 2 3 4 5 Cancel OK Results for Wednesday, November 24, 2021 $7.70 Closing Price 1,035,226 Volume $7.80 Day's High $7.45 Day's Low 1:1 Split Adjustment Nov 10 Nov 17 Nov 24 Dec 1 Dec 8 $7 $8 Currency in USD. Quote data delayed by at least 15 minutes. © Karyopharm, 2020. All Rights Reserved. Terms of Use Privacy Policy Site Map

Logo for Karyopharm Main Menu Events & Presentations Karyopharm Therapeutics 3Q21 Earnings Call Wednesday, November 3, 2021 8:30am - 9:30am EDT Listen to the Webcast View Presentation 2 MB © Karyopharm, 2020. All Rights Reserved. Terms of Use Privacy Policy Site Map